25
Views
20
CrossRef citations to date
0
Altmetric
Original Article

PhoE Protein as a Carrier for Foreign Epitopes

&
Pages 113-121 | Received 15 Sep 1993, Published online: 10 Jul 2009
 

Abstract

Most conventional vaccines consist of killed organisms or purified antigenic parts from these organisms. However this approach of vaccine development has several limitations. First, the large-scale growth of certain pathogenic organisms may be difficult to achieve and is not completely free of risk. Second, it may be difficult to establish whether a certain vaccine preparation is completely killed and free of contaminants. Furthermore, the purification of relevant antigenic parts may be time-consuming and expensive. A more sophisticated method is the use of synthetic peptides corresponding to immunogenic epitopes of pathogens for vaccination. However, such peptides are usually not immunogenic by themselves and therefore, they will have to be coupled to a carrier protein. Another approach is the use of viral carriers, like vaccinia, in which antigenic parts of pathogens can be expressed [1]. However, a serious drawback of this approach is that vaccination with such vectors may lead to disease in immunocompromised individuals. As an alternative for the viral vectors live attenuated bacteria, such as Salmonella aroA mutants [2], could be useful as an expression system for antigens, derived from potential pathogens. Such attenuated Salmonella strains have been shown to induce appropriate humoral, cellular and mucosal immune responses in both animal models and in humans [3, 4, 5]. After oral administration such bacteria can attach to and invade the gut-associated lymphoid tissues and persist for some time in their host. However because of well-defined, non-reverting attenuating mutations [5,6], these bacteria disappear from the host after a limited number of replications. An immune response of the host is not necessary for this process. It has been shown that oral administration of Salmonella gives better immune responses than injection with killed bacteria [7]. Attenuated Salmonella typhi strains are used to vaccinate humans against typhoid fever. Moreover, live attenuated Salmonella strains have been proven to be suitable for the delivery of foreign antigens to the immune system [8, 9]. Thus, such Salmonella strains seem to be a powerful means for raising immune responses, not only to Salmonella itself, but also to foreign proteins expressed in these strains.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.